期刊文献+

多烯紫杉醇磷脂纳米粒在大鼠体内药代动力学及生物利用度研究 被引量:2

Pharmacokinetics and bioavailability of docetaxel-loaded lecithin nanoparticles in rats
下载PDF
导出
摘要 目的研究多烯紫杉醇口服磷脂纳米粒在大鼠体内的药代动力学和口服生物利用度。方法大鼠尾静脉注射多烯紫杉醇注射剂(20μg/g),大鼠单剂量灌胃给予20μg/g多烯紫杉醇溶液,含环孢素A的多烯紫杉醇溶液或含相等剂量多烯紫杉醇的磷脂纳米粒。采用高效液相色谱法检测给药后各时间点血浆中的多烯紫杉醇浓度,评价药代动力学参数和生物利用度。结果多烯紫杉醇口服磷脂纳米粒单剂量灌胃给药后Cmax为(116.19±28.58)pg/L,tmax为1 h,MRT为(5.60±0.34)h,AUC为(490.74±37.28)h.pg.L-1,口服生物利用度是溶液剂的3.65倍。结论磷脂纳米粒能够显著提高多烯紫杉醇的口服生物利用度。 Objective To study the pharmacokinetics and bioavailability of docetaxel-loaded lecithin nanoparticles in rals. Methods Marketed docetaxel injections were intravenously administered to rats at a dose of 20 μg/g. Doeetaxel solution or docetaxel-loaded lecithin nanoparticles was administered orally at a single dose of 20 μg/g. HPLC method was applied to determine the plasma concentralion of docetaxel. Pharmacokinetics and bioavailability of docetaxel-loaded lecithin nanoparticles were investigated in rats after oral administration. Results After single oral administration of docetaxel-loaded lecithin nanoparticles, the calculated Cmaxwas (116.19±28.58) pg/L, tmaxwas 1 h,MRTwas (5.60±0.34) h and AUC was (490.74 +37.28) h ·pg· L^-1 The oral bioavailability of docetaxel-loaded lecithin nanoparticles was 3.65 times of that of docetaxel solution. Conclusion The lecithin nanoparticles can significantly improve the oral bioavailability of docetaxel.
出处 《上海中医药杂志》 2013年第2期79-82,共4页 Shanghai Journal of Traditional Chinese Medicine
基金 上海市科委纳米专项项目(1052nm05100) 上海市教委预算内资助项目(2010JW26)
关键词 多烯紫杉醇 磷脂纳米粒 药代动力学 生物利用度 docetaxel lecithin nanoparticles pharmacokinetics bioavailability
  • 相关文献

参考文献11

二级参考文献66

共引文献38

同被引文献72

  • 1国家药典委员会.中国药典(二部)[s].北京:中国医药科技出版社,2010:附录29,60.
  • 2Atemnkeng MA, Chimanuka B, Dejaegher B, et al. Evaluation of Artemisia annua infusion efficacy for the treatment of malaria in Plasmodium chabaudi chabaudi infected mice [ J ]. Exp Parasitol, 2009, 122(4) : 344-348.
  • 3Ping S, Hour T, Lin S, et al. Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth[J] Urol Oncol, 2010, 28(2) : 170-179.
  • 4Michael J, Dirk M, Edgar J. Generation of wear during the productionof drug nanosuspensions by wet media milling [ J ]. Eur J Pharm Biopharm, 2012. 81(1 ) : 214-222.
  • 5Femando F, Josmar OE, Carmen MD, et al. Dissolution rate enhancemenl of lnratadine in polyvinylpyrmlidone K- 30 solid dispersions by solvent methods [ J ]. Powder Technol, 2013 ( 235 ) : 532-539.
  • 6Fang WR, Deng Y, Li YM, et al. Blond brain barrier permeability and therapeutic time window of GinkgolideB in isehemia-reperfusion injury [J]. EurJ of Pham Sei, 2010, 31(1-3): 8-14.
  • 7Li SM, Liu Y, Liu T, et aL Development and in-vivo assessment of the bioavailability of oridoninsolid dispeions by the gas anti-solvent technique[J]. lntJ Pharmaeeut, 2011, 411(1-2): 172-177.
  • 8Gaueher G, Marchessauh RH, Lernux JC. Polyester-based micelles and nanoparlicles for the parenteral deliveR, of taxanes[ J ]. J Control Release, 2010, 143( i ) : 2-12.
  • 9Liu BR, Yang M, Li R, et al. Tile antitumor effect of nowl doeetaxel- loaded thermosensitive micelles[ J ]. Eur J Phann Biopharm, 2008, 69 (2) : 527-534.
  • 10Jun YJ, Jadhav VB, Min JH, et al. Stable and efficient delivery, of docetaxel by mieelle-encapsulation using a tripodal cyclotriphosphazene amphiphile[J], lnt J Pharnmceut, 2012, 422( 1-2): 374-380.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部